Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) Restructuring Costs (2024 - 2025)

TELA Bio has reported Restructuring Costs over the past 2 years, most recently at $2.1 million for Q4 2025.

  • Quarterly results put Restructuring Costs at $2.1 million for Q4 2025, up 13.69% from a year ago — trailing twelve months through Dec 2025 was $8.2 million (up 14.06% YoY), and the annual figure for FY2025 was $8.2 million, up 14.05%.
  • Restructuring Costs for Q4 2025 was $2.1 million at TELA Bio, down from $2.1 million in the prior quarter.
  • Over the last five years, Restructuring Costs for TELA hit a ceiling of $2.2 million in Q2 2025 and a floor of $1.8 million in Q2 2024.